Latest News and Press Releases
Want to stay updated on the latest news?
-
DANVERS, Mass., July 28, 2017 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ:ABMD) ผู้ให้บริการชั้นนำด้านเทคโนโลยีอันก้าวหน้าในด้านการสนับสนุนหัวใจได้รายงานในวันนี้เกี่ยวกับรายได้ประจำไตรมาสแรกปีงบประมาณ...
-
马萨诸塞州丹弗斯, July 28, 2017 (GLOBE NEWSWIRE) -- 划时代心脏保健技术的领先提供商Abiomed, Inc.（Nasdq:...
-
DANVERS, Mass., July 27, 2017 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ:ABMD), a leading provider of breakthrough heart support technologies, today reported first quarter fiscal 2018 revenue of...
-
DANVERS, Mass., July 06, 2017 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ:ABMD) announced that on Thursday, July 27, 2017, the Company will release financial results for the first quarter of fiscal...
-
DANVERS, Mass., June 30, 2017 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ:ABMD), a leading provider of breakthrough heart support and recovery technologies, announced today the recent publication of a...
-
WASHINGTON, June 09, 2017 (GLOBE NEWSWIRE) -- Nineteen patients who benefitted from treatment with Abiomed’s Impella heart pumps traveled to Washington, D.C. on June 8, 2017, to meet with elected...
-
DANVERS, Mass., May 30, 2017 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ:ABMD), a leading provider of breakthrough heart support technologies, today announced that Michael R. Minogue, Chairman,...
-
DANVERS, Mass., May 09, 2017 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ:ABMD), a leading provider of breakthrough heart support and recovery technologies, announced the debut of the 3rd Generation...
-
马萨诸塞州丹佛斯, May 08, 2017 (GLOBE NEWSWIRE) -- Abiomed 公司（纳斯达克编号：ABMD）是突破性心脏支架技术的领先供应商，它今天宣布 2017 财年第四季度收入达到 1.247 亿美元，比 2016 年同期的 9,400 万美元收入增长 33%。2017 财年的总收入为 4.453 亿美元，比 2016 年的 3.295 亿美元收入增长 35%。在...
-
マサチューセッツ州ダンバース発, May 08, 2017 (GLOBE NEWSWIRE) -- 画期的な心臓サポートテクノロジーのリーディング･プロバイダー、アビオメッド (Abiomed, Inc.、NASDAQ:ABMD) は本日、2017年度第4四半期に1億2,470万ドル (約140億5,600万円) の収入を計上し、2016年度同期の9,400万ドル (約105億9,600万円)...